NCT04250337 · Interventional trial
Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.
Overall registry status Completed
Phase 3
Conditions Atopic Dermatitis
Delaware Valley sites
- Psoriasis Treatment Center of Central New Jersey · East Windsor, NJ · Mercer County
First posted
Registry updated
Added to the directory